Claims for Patent: 5,908,621

✉ Email this page to a colleague

Summary for Patent: 5,908,621

Title:	Polyethylene glycol modified interferon therapy
Abstract:	A method comprising administering a PEG.sub.12000 -IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.
Inventor(s):	Glue; Paul (Flemington, NJ), Cutler; David L. (Morristown, NJ), Affrime; Melton B. (Flemington, NJ)
Assignee:	Schering Corporation (Kenilworth, NJ)
Application Number:	08/839,101
Patent Claims:	1. A method of treating hepatitis C viral infections in mammals which comprises administering PEG.sub.12000 -interferon alpha-2b in an amount of 0.5-2.0 .mu.g/kg in one or two doses per week to mammals in need of such treating. 2. A method of treating hepatitis C viral infections in mammals which comprises administering PEG.sub.12000 -interferon alpha-2b in an amount of 0.5 .mu.g/kg twice per week to mammals in need of such treating. 3. A method of treating hepatitis C viral infections in mammals which comprises administering PEG.sub.12000 -interferon alpha-2b in an amount of 2.0 .mu.g/kg once per week to mammals in need of such treating. 4. A method of treating hepatitis C viral infections in mammals which comprises administering PEG.sub.12000 -interferon alpha-2b in an amount of 0.5, 1.0 or 1.5 .mu.g/kg once per week to mammals in need of such treating .

Details for Patent 5,908,621

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Llc	PEGINTRON	peginterferon alfa-2b	Injection	103949	January 19, 2001	5,908,621	2015-11-02
Merck Sharp & Dohme Llc	SYLATRON	peginterferon alfa-2b	For Injection	103949	March 29, 2011	5,908,621	2015-11-02
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 5,908,621

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
South Africa	983543	⤷ Subscribe
World Intellectual Property Organization (WIPO)	9848840	⤷ Subscribe
World Intellectual Property Organization (WIPO)	9716204	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.